LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanoneedle Bio-patch Provides Minimally Invasive Drug Delivery

By LabMedica International staff writers
Posted on 20 Nov 2018
Image: Silicon nanoneedles embedded in a stretchable and translucent elastomer patch that can be worn on the skin to deliver exact doses of drugs directly into cells (Photo courtesy of Purdue University).
Image: Silicon nanoneedles embedded in a stretchable and translucent elastomer patch that can be worn on the skin to deliver exact doses of drugs directly into cells (Photo courtesy of Purdue University).
A flexible bio-patch made from silicon nanoneedles embedded in a thin layer of elastomer was shown to deliver exact doses of biomolecules to cells and tissues while minimizing discomfort to the wearer.

Vertically ordered arrays of silicon nanoneedles – due to their nanoscale dimension and low cytotoxicity – are capable of minimally invasive nanoinjection of biomolecules into living biological systems such as cells and tissues. Nanoneedle bio-patches are usually fabricated on a bulk silicon wafer that is able to withstand the high temperatures and corrosive chemicals employed in standard nanofabrication processes. These rigid, flat, and opaque silicon wafers do not conform favorably with the soft, curvilinear, and optically transparent biological systems for which they are intended.

To improve this situation, investigators at Purdue University (West Lafayette, IN, USA) developed a unique methodology that enabled construction of vertically ordered silicon nanoneedles on a thin layer of elastomer patch that could flexibly and transparently interface with biological systems.

The investigators reported in the November 9, 2018, online edition of the journal Science Advances that this methodology allowed the heterogeneous integration of vertically ordered silicon nanoneedles with a thin layer of elastomer patch, which could provide a certain degree of mechanical flexibility, optical transparency, and cell and tissue compatibility.

"This means that eight or nine silicon nanoneedles can be injected into a single cell without significantly damaging a cell. So we can use these nanoneedles to deliver biomolecules into cells or even tissues with minimal invasiveness," said senior author Dr. Chi Hwan Lee, assistant professor in of biomedical engineering at Purdue University. "This nanoneedle patch is not only flexible but also transparent, and therefore can also allow simultaneous real-time observation of the interaction between cells and nanoneedles."

Related Links:
Purdue University

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more